Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Šušić, V. (7003269321)"

Filter results by typing the first few letters
Now showing 1 - 3 of 3
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Reduced rapid eye movement sleep latency in patients with parkinson's disease
    (1989)
    Kostić, V.S. (35239923400)
    ;
    Šušić, V. (7003269321)
    ;
    Čovičković-Šternić, N. (6603691178)
    ;
    Marinković, Z. (7003877409)
    ;
    Janković, S. (54914106800)
    Rapid eye movement (REM) sleep latency (time from sleep onset to the first REM episode) was measured in 39 patients with idiopathic Parkinson's disease. Reduced REM sleep latency (≤65.0 min) was found in a high proportion of patients (69%). Since reduced REM sleep latency may be a trait-like abnormality relatively specific to primary depression, we evaluated this parameter in two groups of parkinsonian patients: depressed (16 patients) and non-depressed (23 patients). Its incidence was significantly higher in depressed patients with Parkinson's disease. © 1989 Springer-Verlag.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Reduced rapid eye movement sleep latency in patients with parkinson's disease
    (1989)
    Kostić, V.S. (35239923400)
    ;
    Šušić, V. (7003269321)
    ;
    Čovičković-Šternić, N. (6603691178)
    ;
    Marinković, Z. (7003877409)
    ;
    Janković, S. (54914106800)
    Rapid eye movement (REM) sleep latency (time from sleep onset to the first REM episode) was measured in 39 patients with idiopathic Parkinson's disease. Reduced REM sleep latency (≤65.0 min) was found in a high proportion of patients (69%). Since reduced REM sleep latency may be a trait-like abnormality relatively specific to primary depression, we evaluated this parameter in two groups of parkinsonian patients: depressed (16 patients) and non-depressed (23 patients). Its incidence was significantly higher in depressed patients with Parkinson's disease. © 1989 Springer-Verlag.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Valproate and delta-sleep peptide display high efficacy against metaphit-induced audiogenic seizure in rats
    (2006)
    Stanojlović, Olivera (6602159151)
    ;
    Hrnčić, D. (13907639700)
    ;
    Živanović, D. (6603846587)
    ;
    Rašić, A. (23480382100)
    ;
    Šušić, V. (7003269321)
    The effects of valproate (VPA) and delta sleep-inducing peptide (DSIP) on metaphit-induced generalized, audiogenic seizure in adult rat males were compared. The animals were i.p. injected with: 1. Saline; 2. metaphit (mp, 10 mg kg-1); 3. metaphit (10 mg kg-1) and 8 h later with DSIP (0.1, 0.2, 0.4 or 1.0 mg kg-1), 4. metaphit (10 mg kg-1) and 8 h later with VPA (50, 75 or 100 mg kg-1); 5. DSIP alone (1.0 mg kg-1) and 6. VPA, alone (100 mg kg-1). The rats were exposed to sound stimulation at hourly intervals and the behavior and EEG were analyzed. The EEG signals in metaphit rats appeared as a sleep-like pattern and spike-wave complexes with increased power spectra. Valproate and DSIP reduced the incidence of seizure and prolonged duration of latency in a dose-dependent manner. ED50 of valproate in the 1st hour after administration was 63.19 mg kg-1 and that of DSIP 3.19 mg kg-1 four hours after injection. This suggests that VPA, reached a peak of action immediately after the application, while DSIP had a prolonged action, mildly reducing, but not abolishing metaphit seizure. None of the applied VPA and DSIP doses eliminated the metaphit-provoked EEG signs of epileptiform activity. © 2006 Akadémiai Kiadó, Budapest.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback